Croda International/£CRDA

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Croda International

Founded in 1925, Croda International Plc is a UK-based speciality chemicals company recognized globally for its innovative approach to delivering specialized chemical solutions across a broad range of industries including consumer care and life sciences. Operating within the basic materials sector, Croda develops, manufactures, and markets a wide array of specialty chemicals used in everything from cosmetics and pharmaceuticals to lubricants and plastics. Over the decades, Croda has committed to sustainability and innovation, driving its growth and solidifying its position as in the industry.

Ticker

£CRDA
Sector

Primary listing

LSE

Employees

6,027

CRDA Metrics

BasicAdvanced
£3.8B
27.49
£1.00
0.79
£1.11
4.03%

What the Analysts think about CRDA

Analyst ratings (Buy, Hold, Sell) for Croda International stock.

Bulls say / Bears say

Group sales grew 7.3% at constant currency to £855.8 m in H1 2025, driven by higher volumes in Beauty Care and Crop Protection (Shares Magazine).
Adjusted operating profit rose 11.9% at constant currency to £146.9 m, expanding margins to 17.2% as volume growth and cost efficiencies took effect (Shares Magazine).
Interim dividend per share increased by 1 p to 48.0 p, marking a 2.1% uplift and underscoring robust cash generation and shareholder returns (Croda).
Statutory operating profit fell 17.5% to £94.4 m, weighed down by £27.3 m of impairment charges related to European distribution network rationalisation (MarketScreener).
Sales in Q2 were sequentially lower than Q1 despite 6% year-on-year growth, hinting at decelerating demand momentum in the second half of 2025 (Croda).
Foreign exchange headwinds and adverse price/mix partially offset volume gains, indicating margin susceptibility to macroeconomic shifts (Croda).
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.

CRDA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CRDA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £CRDA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs